Detection of five viruses commonly implicated with Bovine Respiratory Disease using loop-mediated isothermal amplification

preprint OA: closed
📄 Open PDF Full text JSON View at publisher
Full text 2,486 characters · extracted from oa-doi-fallback · click to expand
Abstract Herein, we present novel quantitative loop-mediated isothermal amplification (qLAMP) and reverse-transcription qLAMP (RT-qLAMP) assays for the detection of five viruses commonly implicated with the onset and progression of bovine respiratory disease (BRD): Bovine Alphaherpesvirus Type 1 (BHV-1), Bovine Adenovirus Type 3 (BAV-3), Bovine Respiratory Syncytial Virus (BRSV), Bovine Viral Diarrhea Virus Type 1 (BVDV-1), and Bovine Parainfluenza Virus Type 3 (BPIV-3). Using contrived samples spiked with whole viruses, we found that our extraction-free assays have limits of detection between 30 and 1,057 copies per reaction (1.8% final sample concentration) with minimal sample processing. Using dual-tipped swabs and 1.4 mL resuspension volumes, these limits of detection are on the order of 2 × 105 copies per swab for BAV-3 and BHV-1 and between 6.31 × 106 to 8.22 × 106 copies per swab in the case of BPIV-3, BRSV, and BVDV-1. Analytical sensitivities ranged from 73 – 100% and analytical specificities ranged from 90 – 100%. Additionally, we introduced a streamlined pipeline to minimize the experimental workload to design, screen, select, and characterize LAMP performance for developing assays. The assays targeting these BRD viruses can be utilized to develop colorimetric LAMP assays that enable the sensitive and specific detection of these viruses’ chute side to aid in diagnosing and treating BRD. The associated development pipeline enables more rapid development of LAMP-based diagnostic tools targeting emerging pathogens. Competing Interest Statement The authors declare the following competing financial interest(s): M.S.V., J.P.S., and A.A. have interests in Krishi, Inc., a company interested in licensing and developing on-farm diagnostics technology. The work performed here was not funded by Krishi, Inc. Footnotes Author Contact Information: Josiah Levi Davidson: davids60{at}purdue.edu, Murali Kannan Maruthumuthu: murali.kbiotech{at}gmail.com, Mohamed Kamel: mkamalka{at}purdue.edu, Suraj Mohan: srjmohan{at}gmail.com Ana Pascual-Garrigos: anapascualgarrigos{at}gmail.com, Andres Dextre: adextre{at}berkeley.edu, Ruth Eunice Centeno-Delphia: eunicecentenom{at}gmail.com, Jon P. Schoonmaker: jschoonm{at}purdue.edu, Timothy A. Johnson: john2185{at}purdue.edu, Jacquelyn P. Boerman: jboerma{at}purdue.edu, Deepti Pillai: pillai6{at}purdue.edu, Jennifer Koziol: jkoziol{at}ttu.edu, Aaron Ault: aultac{at}purdue.edu, Mohit S. Verma: msverma{at}purdue.edu

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00